Kidney Transplant News and Research

RSS

A kidney transplant is an operation where a healthy kidney from one person (the donor) is transferred to a person who has little or no kidney function (the recipient).

Frailty: A strong risk factor for dying prematurely after kidney transplant

Regardless of age, frailty is a strong risk factor for dying prematurely after a kidney transplant. The finding, which comes from a new study published in the American Journal of Transplantation, suggests that patients should be screened for frailty prior to kidney transplantation, and that those who are identified as frail should be closely monitored after the procedure.

30 Oct 2014

Fewer women than men receive dialysis treatment for chronic kidney disease

Women with chronic kidney disease receive dialysis treatment far less often than men. However, women suffer more commonly than men from kidney disease. A publication by the MedUni Vienna and the Arbor Research Collaborative for Health, USA, has highlighted this difference based on international patient data.

29 Oct 2014

Researchers create new drug to reduce inflammation of donor organ after transplantation

To reduce the number of discards and thus make more kidneys available, researchers and medical scientists from the European consortium MABSOT have created a new drug called OPN-305 to reduce inflammation of the donor organ after transplantation.

3 Sep 2014

Drug used for treating rheumatoid arthritis can improve health of kidney transplant recipients

UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients.

5 Aug 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

NxStage Freedom Tour launched to educate dialysis patients

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One.

16 Jul 2014

Older kidney donors enjoy similar life expectancy as people who did not donate their kidneys

Previous studies linking older age with kidney and heart disease have raised concerns about the safety of living kidney donation among older adults.

9 Jul 2014

Study: Older kidney donors enjoy similar longevity, cardiovascular health as other healthy individuals

Older kidney donors enjoy similar longevity and cardiovascular health as other healthy mature individuals, according to a new study published in the American Journal of Transplantation.

9 Jul 2014

Advocacy group publicizes child deaths from accidental shootings

Almost two children a week were killed in unintentional shootings during the 12 months that followed the shooting at Sandy Hook Elementary School, according to a report by the gun control group Everytown for Gun Safety.

28 Jun 2014

New data analysis technique improves monitoring of kidney patients

A new data analysis technique radically improves monitoring of kidney patients, according to a University of Leeds-led study, and could lead to profound changes in the way we understand our health.

28 Jun 2014

New partnership in kidney transplantation provides most advanced patient care to Lubbock

UT Southwestern Medical Center and the University Medical Center Health System (UMC) in Lubbock, Texas, have forged a new partnership in kidney transplantation that provides the most advanced patient care, while enabling patients to prepare for and recover from surgery close to home.

16 Jun 2014

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Obese, Caucasian females over age 50 with diabetes and on dialysis because their kidneys have failed are among those at highest risk for the rare and deadly condition calciphylaxis, according to an analysis of the United States Renal Data System.

3 Jun 2014

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

EKF, confirms scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease.

From EKF Diagnostics 23 May 2014

Kidney transplant recipients live longer than patients on intensive home hemodialysis

A first-ever study from a large Canadian centre found that kidney transplant recipients lived longer and had better treatment success than patients on intensive home hemodialysis, but also had an increased risk of being hospitalized within the first year.

23 May 2014

Walking shown to improve clinical outcomes in patients with kidney disease

A recent study indicates that walking can reduce the risks of premature death and the need for dialysis or kidney transplant among patients with kidney disease.

16 May 2014

5-year survival of diabetic kidney transplant patients now on par with nondiabetic recipients

Mayo Clinic researchers have discovered that the five-year survival of diabetic kidney transplant patients is now on par with the five-year survival of nondiabetic kidney recipients.

9 May 2014

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).

6 May 2014

Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease

Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.

26 Apr 2014

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.

23 Apr 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.